Compare AAP & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AAP | HAE |
|---|---|---|
| Founded | 1929 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.7B |
| IPO Year | N/A | 1991 |
| Metric | AAP | HAE |
|---|---|---|
| Price | $52.27 | $84.07 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 20 | 9 |
| Target Price | $52.28 | ★ $79.67 |
| AVG Volume (30 Days) | ★ 1.3M | 1.2M |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.91% | N/A |
| EPS Growth | N/A | ★ 42.54 |
| EPS | N/A | ★ 3.44 |
| Revenue | ★ $8,624,327,000.00 | $1,327,850,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.89 | $6.01 |
| P/E Ratio | ★ N/A | $24.40 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $28.89 | $47.32 |
| 52 Week High | $70.00 | $85.61 |
| Indicator | AAP | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 51.99 | 89.92 |
| Support Level | $50.89 | $80.05 |
| Resistance Level | $54.19 | $81.99 |
| Average True Range (ATR) | 2.06 | 2.16 |
| MACD | 0.56 | 0.04 |
| Stochastic Oscillator | 69.56 | 99.35 |
Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on the basis of inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.